Blog - Page 281 of 5680 - QualityStocks

WednesdayAug 06, 2025 9:00 am

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Expands High-Grade Tin and Silver Zones at Iska Iska Project

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) announced assay results from the first five holes of its restarted definition drilling program in the Santa Barbara starter pit area at the Iska Iska silver-tin polymetallic project in Bolivia. The drilling highlights include 0.89% Sn over 16.5m and 0.90% Sn over 13.5m in hole DSB-78, along with 401.65 g/t Ag over 3.0m in hole DSB-79. All five holes intersected significant tin and silver mineralization, mostly hosted in intrusion breccias, with visible cassiterite likely amenable to gravity separation. Results confirm lateral and downdip continuity, supporting further infill and step-out drilling to expand…

TuesdayAug 05, 2025 12:25 pm

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Market Demand for Breast CT Imaging Innovation

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) emphasized the global trends driving demand for advanced breast cancer imaging technologies and the advantages of its IzoView Breast CT Imaging System. With over 2.3 million new cases of breast cancer diagnosed worldwide annually and U.S. incidence projected to exceed 315,000 in 2025, healthcare systems face growing pressure to improve screening outcomes. Market forecasts show global breast imaging revenues rising from $5.4 billion in 2024 to $8.69 billion by 2030. IzoView addresses clinical and patient needs with non-compressive 3D imaging, offering a more comfortable, accurate, and scalable alternative to conventional modalities—especially for the…

TuesdayAug 05, 2025 11:15 am

HeartBeam Inc.’s (NASDAQ: BEAT) Two New U.S. Patents Power Next Generation of Cardiac Diagnostics

Two newly issued patents mark a strategic advancement in HeartBeam’s proprietary technology. The first patent protects the company’s credit card–sized, cable-free 3D ECG device designed to capture high-fidelity electrical signals from three noncoplanar directions. The second patent covers the company’s rhythm analysis algorithm by continuously analyzing signal input. HeartBeam (NASDAQ: BEAT), a cardiac technology company, has secured two new U.S. patents that significantly enhance its intellectual property portfolio and strengthen its position in cardiac monitoring technology (https://ibn.fm/6xni4). The company, focused on delivering powerful, personalized insights into heart health through its innovative 3D ECG platform, now holds more than 20 U.S.…

TuesdayAug 05, 2025 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Set to Leverage Proprietary Tech, New Trade Deals as Magnetic Materials Gatekeeper

Recent White House announcements with EU and Japan outline tariff guidelines, investment commitments. The confluence of trade policy and industrial investment creates a strategic trade windfall for U.S. critical minerals. Ucore’s proprietary RapidSX technology offers a compelling supply chain solution. Recent trade agreements with the European Union and Japan are unlocking massive investment that could reshape U.S. manufacturing, particularly for critical components such as permanent magnet materials. Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) and its RapidSX(TM) separation technology are strategically positioned to become the North American gatekeeper for magnet-grade rare earth oxides under this new industrial paradigm. Under President…

TuesdayAug 05, 2025 9:45 am

AI Maverick Intel Inc. (BINP): The AI Platform That Might Just Replace Your SDR Team

AI Maverick’s next-gen platform can replicate human-like sales conversations—handling prospecting, objections, and scheduling with no SDR required Recent rollout includes adaptive language models, real-time buying signal detection, and multi-step consultative selling automation Company rebrand reflects shift from biotech to AI-led customer acquisition across sectors like healthcare, transportation, and insurance In a world where sales teams are expected to scale faster than ever, often with fewer resources, the rise of intelligent automation platforms is beginning to redefine how companies engage with prospects. For years, sales development representatives (“SDRs”) have filled the gap between marketing and revenue, conducting outreach, asking discovery questions,…

TuesdayAug 05, 2025 9:40 am

QualityStocksNewsBreaks – InPlay Oil Corp. (TSX: IPO) (OTCQX: IPOOF) Welcomes Delek Group as Strategic Shareholder in Block Sale from Obsidian Energy

InPlay Oil (TSX: IPO) (OTCQX: IPOOF) announced that Obsidian Energy Ltd. has entered a definitive agreement to sell its 9.1 million common shares in InPlay to Delek Group Ltd. The transaction, expected to close in the first half of August 2025, positions Delek as a strategic shareholder with rights to nominate two directors to InPlay’s board. InPlay CEO Doug Bartole highlighted Delek’s strong industry record, including major roles in Ithaca Energy and the Mediterranean’s largest natural gas field. The agreement includes registration and investor rights granting Delek participation and pre-emptive rights in future equity offerings. To view the full announcement,…

TuesdayAug 05, 2025 9:36 am

QualityStocksNewsBreaks – Soligenix, Inc. (NASDAQ: SNGX) Spotlighted in Editorial on Rare Disease Therapeutics

Soligenix (NASDAQ: SNGX) has been featured in a NetworkNewsWire editorial highlighting its progress in addressing rare diseases, particularly among aging populations. The piece emphasizes the urgent need for effective treatments as over 30 million Americans live with rare conditions, many lacking FDA-approved therapies. Soligenix’s HyBryte(TM) platform, targeting cutaneous T-cell lymphoma—a rare skin cancer affecting older adults—represents a promising solution. With successful domestic manufacturing of HyBryte’s active ingredient, the company advances its mission to serve this underserved demographic with innovative, U.S.-based therapies. To view the full press release, visit https://ibn.fm/NfPBX About Soligenix, Inc. Soligenix is a late-stage biopharmaceutical company focused on…

TuesdayAug 05, 2025 9:20 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in Editorial on AI-Driven Hotel Automation

Nightfood Holdings (OTCQB: NGTF) announced its inclusion in a NetworkNewsWire editorial highlighting the rise of AI and robotics in hospitality. The piece details Nightfood’s strategy to integrate Robotics-as-a-Service (RaaS) into hotel operations, including its planned acquisition of a 155-room Holiday Inn in Victorville, California. The property will showcase guest-facing robots for services like food delivery and laundry, powered by subsidiary Skytech. A partnership with Bear Robotics aims to scale automation across Nightfood’s projected $80 million hotel asset portfolio. To view the full press release, visit https://ibn.fm/A8mBW About Nightfood Holdings, Inc. (OTCQB: NGTF) Nightfood Holdings, Inc. is transforming the hospitality industry…

TuesdayAug 05, 2025 9:10 am

QualityStocksNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Prevails in Final Legal Challenge for El Domo Environmental License

Silvercorp Metals (TSX: SVM) (NYSE American: SVM) announced that Ecuador’s Constitutional Court unanimously rejected a final legal challenge against the environmental license for the El Domo mining project, confirming its validity. El Domo, now under construction, is the first mining project in Ecuador to complete an environmental consultation aligned with the Escazú Agreement’s standards. The license was backed by 98% of the local population and has been upheld by multiple judicial levels, including the Constitutional Court. Despite continued obstruction efforts by anti-mining groups, project development remains on track. To view the full press release, visit https://ibn.fm/11dUf About Silvercorp Silvercorp is…

TuesdayAug 05, 2025 9:00 am

Nutriband Inc. (NASDAQ: NTRB) Aligns Shareholder Value with FDA Milestone

FDA approval is a powerful inflection point in the lifecycle of any biopharmaceutical company Nutriband’s recent 25% preferred stock dividend uniquely ties shareholder reward to regulatory achievement CEO notes that “core goal is to continue to create value for our shareholders particularly as we near closer to the commercialization of AVERSA(TM) Fentanyl” Obtaining approval from the U.S. Food and Drug Administration (“FDA”) is a monumental achievement for any biopharmaceutical company, serving as a critical validation of a drug's safety and efficacy. This rigorous process is a cornerstone of public health, ensuring that only treatments proven to be beneficial and with acceptable…

Site Search

Company Search